Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 1;13(1):115-118.
doi: 10.21037/hbsn-23-624. Epub 2024 Jan 17.

Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations

Bo Kyung Koo  1   2 , Dong Hyeon Lee  2   3 , Jeong Hwan Park  4 , Won Kim  2   3
Affiliations
Editorial

Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations

Bo Kyung Koo et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Nonalcoholic fatty liver disease (NAFLD); PNPLA3-rs738409; cirrhosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-624/coif). The authors report that this study was supported by Korea National Institute of Health (2022ER090700). The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
The risk of fibrosis progression according to PNPLA3 rs738409 genotype and diabetes at baseline in FIB-4 <1.3, 1.3–2.67, and >2.67 at baseline. The cumulative incidence of fibrosis progression in patients with NAFLD, which was defined as LSM ≥9.6 kPa for patients with F0–2 at baseline and ΔLSM ≥+20% compared to the baseline level for patients with F3–4 at baseline during the follow-up period. FIB-4, fibrosis-4 index; DM, diabetes mellitus; HR, hazard ratio; CI, confidence interval; NAFLD, nonalcoholic fatty liver disease; LSM, liver stiffness measurement.
Figure 2
Figure 2
The ethnic difference in the risk of NAFLD according to PNPLA3 rs738409 genotype. Meta-analysis for the ethnic difference in the risk of NAFLD (A) and NASH among NAFLD subjects (B), according to PNPLA3 rs738409 genotype. OR, odds ratio; SE, standard error; CI, confidence interval; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis.
See this image and copyright information in PMC

Comment on

References

    1. Stern C, Castera L. Identification of high-risk subjects in nonalcoholic fatty liver disease. Clin Mol Hepatol 2023;29:S196-206. 10.3350/cmh.2022.0431 - DOI - PMC - PubMed
    1. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023;77:1797-835. 10.1097/HEP.0000000000000323 - DOI - PMC - PubMed
    1. Kanwal F, Shubrook JH, Adams LA, et al. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2021;161:1657-69. 10.1053/j.gastro.2021.07.049 - DOI - PMC - PubMed
    1. De Vincentis A, Tavaglione F, Jamialahmadi O, et al. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. Clin Gastroenterol Hepatol 2022;20:658-73. 10.1016/j.cgh.2021.05.056 - DOI - PubMed
    1. Chen VL, Oliveri A, Miller MJ, et al. PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis. Gastroenterology 2023;164:966-977.e17. 10.1053/j.gastro.2023.01.040 - DOI - PMC - PubMed